In adults with AMI who are at risk for HF, empagliflozin did not reduce a composite of first HF hospitalization or all-cause death at 18 mo.
Where this comes from
- Record sourced from PubMed, PMID 38950404.
- Also identified by DOI 10.7326/ANNALS-24-00809-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Butler J, Jones WS, Udell JA, et al. <b>Empagliflozin after acute myocardial infarction.</b> N Engl J Med. 2024;390:1455-1466. 38587237.
Medical subject headings
- Benzhydryl Compounds
- Glucosides
- Heart Failure
- Hospitalization
- Myocardial Infarction
- Sodium-Glucose Transporter 2 Inhibitors